IKT EBITDA
Inhibikase Therapeutics Inc · EBITDA
IKT EBITDA
Latest reported-$62.34Mperiod ending
IKT EBITDA ($0.00 → -$62.34M)
Annual EBITDA
High-resolution chart · PNG
IKT ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -53,287,726 | |
| -27,493,614 | |
| -18,851,485 | |
| -18,047,432 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |